Loading…
Aarey Drugs & Pharmaceuticals (AAREYDRUGS)₹109.04−0.16%Pharmaceuticals
At the end of the Jun 2026 quarter, Aarey Drugs & Pharmaceuticals' shareholders were: promoters 37.72%, FIIs 4.83%, DIIs 1.63%, public 55.82%. Promoter holding is unchanged on the quarter. FII holding is up 2.85 percentage points from 1.98% a year earlier. 0.00% of promoter shares were pledged. It had 13,480 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.05% | 50.05% | 45.29% | 45.29% | 45.45% | 44.81% | 44.81% | 44.81% | 44.81% | 39.06% | 37.72% | 37.72% |
| FIIs | 3.96% | 3.85% | 3.42% | 3.42% | 2.76% | 2.35% | 2.35% | 1.98% | 1.14% | 3.88% | 4.20% | 4.83% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.63% | 1.63% |
| Public | 45.99% | 46.10% | 51.29% | 51.29% | 51.79% | 52.84% | 52.84% | 53.21% | 54.05% | 57.06% | 56.45% | 55.82% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 16,088 | 15,271 | 16,845 | 16,181 | 16,678 | 16,290 | 16,259 | 15,798 | 14,899 | 14,065 | 14,190 | 13,480 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Bina Rajesh Ghatalia | Promoter | 14.15% | 0.00 |
| Mihir Rajesh Ghatalia | Promoter | 9.97% | 0.00 |
| Nimit Impex | Promoter | 7.14% | 0.00 |
| Nimit Rajesh Ghatalia | Promoter | 4.10% | 0.00 |
| Elysian Wealth Fund | FII | 3.14% | 0.00 |
| Mira Mihir Ghatalia | Promoter | 2.42% | 0.00 |
| Krishnamurthy C G | Public | 1.75% | 0.00 |
| Suvi Rubber Pvt Ltd | Public | 1.66% | −0.47 |
| Shree Salasar Properties And Finance Private Limited | DII | 1.63% | 0.00 |
| Chetan Kirtibhai Mehta | Public | 1.40% | 0.00 |
| Richa Bothra | Public | 1.37% | +0.10 |
| Resonance Opportunities Fund | FII | 1.06% | 0.00 |
| Vijay Kumar Babulal Shah | Public | 1.05% | 0.00 |
| Kls Commodities Private Limited | Public | 1.03% | New |
| Rajesh Pranlal Ghatalia | Promoter | 0.01% | 0.00 |
| Mvm Commodities Private Limited | Public | Exited | — |
| Suraj Tradelinks | Promoter | 0.00% | 0.00 |
Promoters held 37.72% of Aarey Drugs & Pharmaceuticals at the end of the Jun 2026 quarter, down 7.09 percentage points from 44.81% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 4.83% (up 0.63 percentage points from 4.20% a quarter earlier) and domestic institutions (DIIs) held 1.63% (unchanged at 1.63% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Aarey Drugs & Pharmaceuticals had 13,480 shareholders at the end of the Jun 2026 quarter, against 15,798 a year earlier.
Elysian Wealth Fund (FII) held 3.14% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.